Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Healthcare Biotechnology Medical Instruments & Supplies
Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Spectral Medical Inc > So it is Baxter adding to their Spectral investment
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(335)
•••
Post by hmmmmmmmmon Oct 29, 2022 8:58pm
372 Views
Post# 35058165

So it is Baxter adding to their Spectral investment

So it is Baxter adding to their Spectral investmentBaxter has invested an additional US$2,500,000. into Spectral through "notes".

It is great news that Baxter is backing the Tigris trial with another 2.5million dollar investment. So why did Spectral try to bury the news with the whole "strategic commercial partner" nonsense?

Is it more withholding of material info?

Was Spectral worried that the share price could rise on news of further Baxter investment- before the financing?

Time to commit to being transparent Seto. (confirmed partner #2?, Baxter milestone payment secrets?)

 "Agency Agreement"
"Pinnacle Island L.P. (“Pinnacle”), pursuant to the terms of that certain securities purchase agreement to be entered into by the Corporation and each subscriber of Notes (the “Subscription Agreement”), and pursuant to which Baxter has agreed to purchase US$2,500,000 million in Notes"

Thankfully there are legal filings that reguire the info that's somehow withheld from offical News Releases.
Starts on bottom of pg 1:
https://www.sedar.com/GetFile.do?lang=EN&docClass=13&issuerNo=00002006&issuerType=03&projectNo=03443410&docId=5299077
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities